Coverage and support available for patients with Huntington’s disease (HD) chorea

Use the prescription coverage tool at the bottom of this page to find which health plans cover AUSTEDO in your state.

Affordability through financial assistance programs

~90% pie chart.

~90% of patients pay $10 or less per month for AUSTEDO1

  • AUSTEDO Copay Program: As little as $0 copay
    per month for eligible, commercially insured
  • AUSTEDO Free Trial: Offer available for patients
    new to AUSTEDO (includes sampled patients)

Free Trial Vouchers and Copay Coupons available for patients starting on AUSTEDO at

Comprehensive coverage helps make AUSTEDO more accessible1

~80% pie chart.

~80% of prescriptions are successfully processed and approved1

  • Access for 90% of patients with insurance
    coverage (commercial, Medicare Part D, and Medicaid)1
  • Available at both specialty and retail pharmacies

Reach out to us, we’ll handle the details.

Learn more about getting started with Shared Solutions®

Blue prescription coverage tool icon

coverage tool

Find health plans that cover AUSTEDO in your state

Find health plans that cover AUSTEDO in your state

Enter in a ZIP code or select a state, then select a plan type, select a plan, and click “Search.”



  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

Plan Type

  • Commercial
  • EGWP
  • Employer
  • Fed Prog
  • HIX
  • MAC A
  • MAC B
  • Managed Medicaid
  • Medicare MA
  • Medicare PDP
  • Medicare SN
  • Medi-Medi
  • Municipal Plan
  • PACE
  • PBM
  • Pvt HIX
  • State Medicaid
  • Union

Select Plan

    NA, not available.
    Please note that plans may have multiple formularies and they are subject to change by the plan. Please check with the health plan directly to confirm formulary status, requirements, and coverage information for individual patients.
    Source: Fingertip Formulary database as of 01/2022.

    Terms and Conditions for the AUSTEDO Copay Program: The AUSTEDO Copay Program is available to eligible patients who have been prescribed AUSTEDO and have commercial insurance. Eligible patients may pay as little as $0 on each fill. Maximum annual benefits apply and out-of-pocket expenses may vary. Patient is responsible for costs above maximum benefit amounts. This Program is restricted to residents of the United States and United States territories. Uninsured and cash-paying patients are NOT eligible for this Program, nor are patients with commercial insurance that does not provide coverage for AUSTEDO (except in certain limited situations while a prior authorization is pending). Patients enrolled in any state or federally funded healthcare program, including but not limited to, Medicare, Medigap, Medicaid, VA, DOD, TRICARE, Puerto Rico Government Health Insurance Plan, and Medicare-eligible patients enrolled in an employer‑sponsored health plan or prescription drug benefit program for retirees, are NOT eligible for this Program. Teva Neuroscience, Inc. and its affiliates reserve the right to change, rescind, revoke, or discontinue this Program at any time without notice. Please see complete Terms and Conditions at


    Certain restrictions apply for Free Trial Vouchers and Copay Coupons. Copay Coupons are not available for patients eligible for Medicare, Medicaid, or any other form of government insurance coverage. Terms and conditions on

    REFERENCE: 1. Data on file. Parsippany, NJ: Teva Neuroscience, Inc.